2؉ spikes that were enhanced by 3,9-dimethylxanthine, an activator of RYs. Analysis of RNA from islets and insulin-secreting ␤TC-3-cells by RNase protection assay, using type-specific RY probes, revealed low-level expression of mRNA for the type 2 isoform of the receptor (RY 2 ). We conclude that in situ activation of RY 2 in beta cells requires cAMPdependent phosphorylation, a process that recruits the receptor in a functionally operative form.
Ryanodine receptors (RY) are Ca 2ϩ channels in the endoplasmic reticulum (ER) composed of four Ϸ550-kDa RY protomers and four molecules of FKBP12 or FKBP12.6. The latter are isoforms of the 12-kDa binding protein for the immunosuppressant drug FK506. cDNAs for three RYs have been cloned. Ryanodine RY 1 , RY 2 , and RY 3 receptors are products of three genes (1) . Truncated and splice variants of RYs have been described, all of which might associate in the form of homo-or heterotetramers to produce large diversity of the channels. FKBP12 and FKBP12.6 associate with RY 1 and RY 2 , respectively, and stabilize the channel (2) . Studies in cell-free systems have demonstrated that activity of RYs can be modulated by numerous factors including phosphorylationdephosphorylation, Ca , and cyclic ADP ribose (3, 4) . However, it is less clear how activity of RYs is modulated in their native environment in the intact cells.
High expression of RYs typically occurs in a few electrically excitable cells, e.g., striated muscles and some neurons. In most cells, the level of expression of RYs is low, often making their detection by conventional methods difficult (1) . The existence and roles of RYs in beta cells have remained controversial. Some investigators claim crucial importance of RYs in Ca 2ϩ signaling in beta cells (5) (6) (7) , whereas others favor the idea of total absence of them (8) . One difficulty in resolving the controversy derives from difficulty in obtaining a large number of pure beta cells, which are nested in the islet with many other cells. For this reason most studies have attempted to obtain indirect information on the presence of RYs, by measuring cytoplasmic-free [Ca 2ϩ ] ( [Ca 2ϩ ] i ) in single beta cells and relying on agents such as caffeine, ryanodine, sulfhydryl agents, and cyclic ADP ribose (9) (10) (11) . Development of ligands capable of discriminating between the isoforms of RYs so far has been met with limited success (12, 13) . Instead, sensitive molecular biological techniques are being used for identification of RY types in different tissues (14) .
Caffeine remains the most useful tool for activating RYs. Unfortunately, the effects of caffeine on [Ca 2ϩ ] i in beta cells are complex. When applied to resting beta cells, high concentrations of caffeine (e.g., 10-50 mM) increase [Ca 2ϩ ] i by inhibiting K ϩ ATP channels and thereby depolarizing the plasma membrane and allowing Ca 2ϩ entry through voltage-gated Ca 2ϩ channels (10). On the other hand, when applied to beta cells whose [Ca 2ϩ ] i is first raised by depolarization, caffeine reduces [Ca 2ϩ ] i by inhibiting the L-type voltage-gated Ca 2ϩ channels. In contrast to these, a consistent Ca 2ϩ -releasing effect of caffeine in beta cells has been difficult to demonstrate (10, 11, 15) . These observations prompted us to find out the conditions that could ensure more consistent activation of RYs by caffeine. We demonstrate that in intact beta cells, cAMP-dependent phosphorylation is an important requirement for achieving activation of RYs by pharmacological probes as well as by physiological stimuli. Using a sensitive RNase protection assay and type-specific probes, we demonstrate that the RY isoform involved in this process in beta cells is RY 2 .
MATERIALS AND METHODS
Materials. 4-chloro-3-ethylphenol was from Aldrich. SpcAMPS was from Biolog, Bremen, Germany. 3,9-Dimethylxanthine was from Fluka. Fura-2 AM and Indo-1 were from Molecular Probes Europe. Ryanodine (Ϸ98% pure) was from Calbiochem. ␤-Alanyl ryanodine was a gift from Henry R. Besch, Jr. (Indiana University).
Measurements of [Ca 2؉ ] i in Beta Cells. Islets from ob͞ob mice were isolated and cells were cultured on glass coverslips for 24-48 hr in RPMI 1640 medium, supplemented with 10% fetal bovine serum (10) . Coverslips were incubated in RPMI 1640 with 0.1% BSA and 0.6 M fura-2 AM for 35 min at 37°C. Cells were then incubated for a further 10 min in the basal medium containing 125 mM NaCl, 5.9 mM KCl, 1.2 mM MgCl 2 , 1.28 mM CaCl 2 , 25 mM Hepes, 3 mM glucose, and 0.1% BSA (pH 7.4). The coverslip was mounted in a chamber on an inverted microscope. The temperature inside the chamber was 37°C. The microscope was connected to a SPEX fluorolog-2 CM1T11I system. The excitation wave-lengths were generated by two monochromators, and the emitted light, selected by a 510-nm filter, was monitored by a photomultiplier. Cells were excited at 1 Hz, and the length of time for data collection at each point was 0.33 s. The emissions at the excitation wavelengths of 340 nm (F 340 ) and 380 nm (F 380 ) were used to calculate the fluorescence ratio (R 340͞380 ). Single cells or clusters of two to three cells, isolated optically, were studied by a ϫ40, oil-immersion lens. R max and R min were determined by using thin films of external standards containing fura-2 and 2 M sucrose (16 with StyI and transcribed with T7 polymerase to obtain a 300-bp antisense RY 2 probe. MTII11 was linearized with BglII and transcribed with T3 RNA polymerase to obtain a 420-bp RY 3 probe. The probes were purified on a 4% polyacrylamide, 7 M urea gel.
RNase protection assay. RNA was analyzed by RNase protection assay using the RPAII kit (Ambion, Austin, TX). Usually, 1-60 g of the RNA was hybridized to 1 ϫ 10 5 cpm of the RNA probe. The hybrids were subjected to digestion with 8 units RNase T1 and 0.2 Kunitz units RNase A and separated on a 6% polyacrylamide, 7 M urea sequencing gel. The gel was transferred to filter paper, dried, and exposed to screens for phosphor imaging. The resulting bands were ana- 
RESULTS
A previous protocol for detecting release of Ca 2ϩ by caffeine from ER in beta cells resulted in a low success rate (10) . In the present study we used a different protocol, arbitrarily designed to increase the probability and magnitude of Ca ] i in any of the 15 cells examined (Fig. 1B) (Fig. 1C) . Under similar conditions, Sp-cAMPS (200 M), a phosphodiesterase-resistant membrane-permeable cAMP analogue that activates PKA, also did not increase [Ca 2ϩ ] i (Fig. 1D) . However, as illustrated in Fig. 1D , Sp-cAMPS also permitted caffeine to produce Ca 2ϩ spikes. Examination of a large number of cells revealed that when 10 mM caffeine was used alone, a Ca 2ϩ spike was obtained in only 14% of cells examined (n ϭ 21). This value increased to Ϸ60% (n ϭ 21) when forskolin was added before the addition of caffeine (Fig. 2) . The interval between the arrival of caffeine to the chamber and the occurrence of the Ca 2ϩ spike varied between cells and could be as long as 5 min (median 33 s, n ϭ 11). In the presence of forskolin, increase in [Ca 2ϩ ] i during the caffeine-induced spike was 825 nM Ϯ 135 nM (n ϭ 10). The spikes were consistent in shape with half-height width of 4.3 Ϯ 0.3 s (n ϭ 10). As shown in (Fig. 2) .
Because the existence of RYs in beta cells has been a matter of controversy and caffeine has pleiotrophic effects (10), we used another activator of RY, namely, 4-chloro-3-ethylphenol (4-CEP) (19) . Using skeletal muscle, a cell type in which expression of RYs is well defined, we examined whether 4-CEP can activate RYs in situ and at resting conditions. In muscle cells injected with Indo-1, 4-CEP (200 M) increased [Ca 2ϩ ] i , which reached a plateau in Ϸ3 min (Fig. 3A) and reversed on washout. To test whether this phenolic compound might damage cells, we measured the force of contractions of fibers on electrical stimulation before and after 8 min of exposure to 4-CEP. As shown in Fig. 3B , the forces of contraction under the two conditions were equal. ␤-Alanyl ryanodine, an activator-selective analog of ryanodine (20) ] i being Ϸ100 M. Clear and consistent increase was obtained with 500 M 4-CEP, and the substance was used at this concentration in subsequent experiments (Fig. 4A) ] i ϭ 38 Ϯ 3 nM in controls and 28 Ϯ 4 nM in the ryanodine-treated group; n ϭ 11, P ϭ 0.16).
We then tested whether a RY might be involved in a glucoseinduced increase in [Ca 2ϩ ] i . As shown in Fig. 5 , addition of forskolin to beta cells whose [Ca 2ϩ ] i was first elevated by glucose stimulation resulted in the appearance of a few Ca 2ϩ spikes. To test whether a RY might be involved in generation of some of these spikes, we used 3,9-dimethylxanthine (3,9-DMX). This xanthine derivative, like caffeine, is an activator of RY (21) and produces Ca 2ϩ spikes when used in protocols like that of Fig. 1 (data not  shown) . However, unlike caffeine, 9-substituted methylxanthines do not inhibit cAMP phosphodiesterases (ref. 22 and our unpublished results). Another reason for not using caffeine in these experiments was that it inhibits plasma membrane Ca 2ϩ channels (10) . As shown in Fig. 5 , forskolin-induced Ca 2ϩ spikes were enhanced by 5 mM 3,9-DMX in all of the cells examined, suggesting involvement of RYs in the generation of such spikes. Under similar conditions but in the absence of forskolin, 3,9-DMX induced diminutive and low-frequency spikes in a smaller proportion of cells.
To detect the isoforms of RYs that are expressed in beta cells, we analyzed RNA obtained from ob͞ob islets, where Ϸ95% of the endocrine cells are beta cells. Because expression of RYs in beta cells might be low, we used RNase protection assay instead of Northern blot analysis to obtain greater sensitivity. We used radiolabeled cRNA fragments of mouse RY 1 , RY 2 , and RY 3 as (1998) probes that could identify regions demonstrating a high degree of divergence between the isoforms. The lengths of the protected RY 1-3 cRNA fragments were demonstrated by incubating the respective probes with RNA from mouse skeletal muscle (RY 1 , 350 bp, Fig. 6 , lane 3), heart (RY 2 , 300 bp, lanes 11 and 12), and brain (RY 3 , 420 bp, lane 7), respectively. The RY 2 cRNA probe was protected by mRNA (lane 13) and total RNA (lane 14) from islets. The length of the protected segment was shorter than the undigested probe and equal to the length of the segment protected by RNA from heart (lanes 11 and 12). We considered the possibility that cells other than beta cells in the islet might be the source of RY 2 mRNA. To exclude this, we examined RNA from an insulin-secreting cell line, ␤TC-3. As shown in Fig. 6 , lanes 15 and 16, positive signals with appropriate lengths also were obtained with RY 2 probe and ␤TC-3 RNA. We also examined RNA from ␤TC-3 cells with RY 1 and RY 3 probes, but no convincing signals were detected. These results suggest the presence of RY 2 or RY 2 -like transcripts in beta cells. The bands, however, were faint and the estimated amount of transcript in islets was at least 1,000-fold less, compared with the amount per microgram of total RNA detected in heart.
DISCUSSION
Previous studies, using experimental conditions adequate for detecting depolarization-and Ins(1,4,5)P 3 -induced increases in [Ca 2ϩ ] i , failed to obtain Ca 2ϩ release by caffeine in beta cells (10, 11, 23) . We suspected that the protocols used in those studies were not adequate to achieve the conditions for in situ activation of RYs. Through preliminary experiments we worked out a new protocol, which when used in this study yielded Ca 2ϩ release by caffeine. The current protocol, which uses prior stimulation of the cells by glucose, is likely to improve cellular energy status and ensure a higher degree of filling of the Ca Proc. Natl. Acad. Sci. USA 95 (1998) evident because elevation of the cellular cAMP level, as would occur on exposure to forskolin alone, did not release Ca 2ϩ , an observation consistent with previous studies (24) . Similarly, high concentrations of Sp-cAMPS, a phosphodiesterase-resistant analogue of cAMP that activates PKA, also did not release Ca 2ϩ by itself but mimicked the effect of forskolin by permitting caffeine to produce Ca 2ϩ spikes. 4-Chloro-m-cresol is a new tool for activating RYs (19) . We demonstrate that 4-CEP, a lipophilic analogue of 4-chloro-mcresol, induced small but consistent Ca 2ϩ release from ER in beta cells. 4-CEP-induced Ca 2ϩ release was enhanced by caffeine, indicating that the release was mediated by a RY. However, 4-CEP-induced Ca 2ϩ release was not inhibited significantly by ryanodine, an observation consistent with a previous report (25) . This may be because of the difficulty in delivering ryanodine into attached cells and in achieving the conditions for ryanodine binding in intact cells. This view is supported by the lack of effect of ␤-alanyl ryanodine in our skeletal muscle experiments (Fig. 3C) . Conditions that favor ryanodine binding in cell-free systems, e.g., high ionic activity and low [Mg 2ϩ ], cannot be obtained in living cells (3) . It is noteworthy that as with caffeine-induced Ca 2ϩ release, 4-CEP-induced Ca 2ϩ release also was enhanced by forskolin, giving rise to Ca 2ϩ spikes.
Ca 2ϩ release through the RYs and requirement of cAMPdependent phosphorylation in this process was demonstrated even under conditions of physiological stimulation of beta cells by glucose. Thus once [Ca 2ϩ ] i was raised by glucose, addition of forskolin alone induced Ca 2ϩ spikes. Apparently forskolininduced phosphorylation of RYs made them available for activation by Ca 2ϩ , the endogenous agonist of RY 2 . That RYs were involved in this process was further supported by the observation that in glucose-stimulated cells, forskolin-induced Ca 2ϩ spikes were enhanced by 3,9-DMX. This methyl xanthine, like caffeine, is an activator of RYs but, in contrast to the latter 3,9-DMX, does not inhibit Ca 2ϩ entry through the plasma membrane Ca 2ϩ channels, does not depolarize the plasma membrane, and probably does not inhibit cAMP-phosphodiesterases (10, 21, 22) . Our RNase protection assay detected low-level expression of a RY 2 -like transcript in beta cells. As alluded to earlier, in many other cells the level of expression of RY mRNAs also is low, usually requiring reverse transcription-PCR amplification for their detection (26) . The physiological significance of RY 2 -mediated Ca 2ϩ release in beta cells is not fully clear. However, despite their low level these channels may play a role in complex Ca 2ϩ signaling in the beta cells by virtue of their high conductance or strategic intracellular location.
cAMP-dependent phosphorylation has been shown to modulate activity of RY 2 in cell-free systems (27) . Here we demonstrate that RY 2 is not readily activated by caffeine in the live beta cells. But once RY 2 or intermediate protein(s) involved in the regulation of the channel is phosphorylated by PKA, Ca 2ϩ release occurs in the form of spikes. Such spikes are likely to represent synchronous activation of multiple RY 2 . It appears that in the absence of PKA phosphorylation, RY 2 is maintained in an inactive state probably via the inhibitory effect of intracellular Mg 2ϩ (27) . PKA-mediated phosphorylation apparently enables RY 2 to overcome this inhibition, thus effectively recruiting the receptors in a form that can be readily activated. Some of the controversial results on RYs in beta cells reported so far may be accounted for by the differences in the state of phosphorylation of the receptor (or its regulatory proteins) under different experimental conditions. The implications of these findings can be extended to other cells where RY 2 is expressed at a low level. Thus, experimental protocols that cannot ensure cAMP-mediated phosphorylation of RY 2 are less likely to obtain Ca 2ϩ release by caffeine. 
